Epistaxis Global Clinical Trials Review, H2, 2017

2017-08-11
Price :
Published : Aug-2017
No. of Pages : 53

Epistaxis Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Epistaxis Global Clinical Trials Review, H2, 2017” provides an overview of Epistaxis clinical trials scenario. This report provides top line data relating to the clinical trials on Epistaxis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Mylan NV (MYL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, cardiovascular, central nervous systems, infectious disease, oncology, anesthesia and others. Mylan sells its products to retail pharmacy chains, wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies. The company has research and development facilities in the US, Canada, the UK, Ireland, Italy, Germany, India and Japan. Mylan is headquartered in Hatfield, Hertfordshire, the UK......
$250

Koninklijke Philips N.V. (PHIA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical systems, consumer electronics and lighting products. It offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare solutions. The company provides health & wellness, personal care and domestic appliances. Philips offers consumer luminaires, lumileds, professional lighting solutions, light sources & electronics and automotive lighting. The company also focuses on offering green products such as dimming backlights, and image processing inte......
$250

Albany Molecular Research Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Albany Molecular Research Inc (AMRI) is a contract research and manufacturing organization. Its service portfolio drug discovery and development, manufacturing of Active Pharmaceutical Ingredients (API); process scale up development of fine chemicals and aseptic filling services for preclinical, clinical and commercial projects; manufacture of drug product (DP) for new and generic drugs and project management services. The company serves pharmaceutical, agrochemical and other sectors including detergent and cosmetics industries. AMRI offers drug discovery and development services across various therapeutic categories including infectious diseases, neurodegenerative disorders, metabolic disorders, cardiovascular and oncology. It has presence in the US, Europe and Asia. AMRI is head......
$250

PTC Therapeutics Inc (PTCT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mutation; an orally active small molecule to reduce the function, activity and amount of BMI1; and an investigational oral therapeutic used for the treatment of spinal muscular atrophy. PTC Therapeutics' ataluren is in phase 3 for the treatment of nonsense mutation duchenne muscular dystrophy.The company works in collaboration with various biotechnology and pharmaceutical companies for advancing its pipeline candidates. PTC Therapeutics is headquartered in South Plainfield, New Jersey, the US. P......
$250

Chemical Company of Malaysia Berhad (CCM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Chemical Company of Malaysia Berhad (CCM) is an industrial and specialty chemicals company. Its core business activities include provision of pharmaceuticals and healthcare products; chemical products and applications; and polymer coatings and applications. The company's product range find applications in a wide range of industries. CCM develops, manufactures and manufactures generic drugs and branded pharmaceutical products; provides water treatment solutions; and the polymer coating solutions for the rubber gloves industry. It also provides over-the-counter (OTC) brands such as CHAMPS, Diamelon, Donna, Flavettes and Proviton. The company has regional offices in Singapore, Indonesia and the Philippines. CCM is headquartered in Kuala Lumpur, Malaysia. Chemical Company of Malaysia......
$250

Amarin Corp Plc (AMRN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa (icosapent ethyl) is a US FDA approved single-molecule prescription capsule used as an adjunct to diet, for the reduction of triglyceride levels in adult patients with severe hypertriglyceridemia and high triglyceride levels or mixed dyslipidemia. The company is also evaluating Vascepa as an add-on therapy to reduce major cardiovascular events in an at-risk patient population on statin therapy. Amarin markets the product in the US through wholesalers and specialty pharmacy providers. The company has subsidiaries in Ireland, the US, Scotland and Israel. Amarin is headquartered at Dublin, Ireland. Amarin Corp Plc (AMRN) - ......
$250

Verona Pharma Plc (VRP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilator/anti-inflammatory drug which is being developed for a wide range of indications including chronic obstructive pulmonary disease (COPD), cystic fibrosis and asthma. The company has collaborations with King's College London McGill University and The University of North Carolina for conducting research and experimental studies and to the fund exploratory studies. The company has operations in North America and the UK. Verona Pharma is headquartered in London, the UK. Verona Pharma Plc (VRP) - ......
$250

Codexis Inc (CDXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company's product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs), Codex screening panels and kits, and enzyme platforms. It also offers a wide range of biocatalysis solutions ranging from screening and optimization to commercial supply of biocatalysts. Codexis discovers, identifies, optimizes and produces enzymes by using its technology platforms such as CodeEvolver, protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. The company serves specialist businesses, pharmaceutical, food manufac......
$250

Owens & Minor Inc (OMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and surgical products related to admission, anesthesia, diagnostics and equipment, maternity and nursery, O.R. products, patient care, respiratory, and urology. It also offers distribution services and supply-chain management services to healthcare providers and suppliers of medical and surgical products. The company offers its products and services to independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare products' manufacturers, and the federal gov......
$250

ArQule Inc (ARQL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including activated checkpoint therapy platform and c-met survival protein platform. Its lead product candidate, ARQ 197 (tivantinib), an inhibitor of the c-Met receptor tyrosine kinase, is undergoing clinical-stage development. The other product pipeline of the company includes ARQ 087 is a multi-kinase inhibitor, ARQ 092 is an Akt inhibitor, ARQ 751 is a next-generation inhibitor of Akt, ARQ 761 is an activator of the damage response pathway, , ARQ 531 is a B-cell malignancies and ARQ 087 is an inhibi......
$250